<DOC>
	<DOCNO>NCT01148108</DOCNO>
	<brief_summary>This Phase 2 study determine efficacy safety canfosfamide treatment relapse refractory mantle cell lymphoma , diffuse large B cell lymphoma multiple myeloma . The study conduct two stage 5-6 patient indication Stage 1 response observe additional 10 patient Stage 2 group .</brief_summary>
	<brief_title>Study Canfosfamide Refractory Relapsed Mantle Cell , Diffuse Large B Cell Lymphoma Multiple Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Mantle-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<criteria>relapse refractory disease histologically cytologically confirm disease characteristic immunophenotypic profile measurable disease ( lymphoma patient ) ECOG performance status 02 adequate liver kidney function adequate bone marrow reserve ineligible unwilling undergo autologous stem cell transplantation failure recover major surgery within 4 week study entry pregnant lactate woman woman childbearing potential use reliable appropriate contraception routine prophylactic use GCSF require within 2 week study entry Grade 3 high peripheral neuropathy history hepatitis B virus HIV central nervous system meningeal involvement lymphoma multiple myeloma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>NHL</keyword>
	<keyword>Non-Hodgkins Lymphoma</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Mantle Cell</keyword>
	<keyword>Diffuse Large B Cell</keyword>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Telcyta</keyword>
	<keyword>canfosfamide</keyword>
	<keyword>TLK286</keyword>
	<keyword>Prodrug</keyword>
	<keyword>Enzyme activate drug</keyword>
	<keyword>Glutathione Transferase P1-1 activate drug</keyword>
	<keyword>GSTp1-1 activate drug</keyword>
	<keyword>Glutathione Transferase activate drug</keyword>
	<keyword>Glutathione</keyword>
	<keyword>Glutathione analong</keyword>
</DOC>